Drug Type CAR-T |
Synonyms anti-CD22 CAR-T therapy, Anti-CD22 chimeric antigen receptor T-cell therapies |
Target |
Mechanism CD22 modulators(CD22 modulators), Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Phase 1 | CN | 08 Jun 2019 | |
Multiple Myeloma | Phase 1 | CN | - |